Teradyne (TER) Tops Q2 EPS by 3c, Beats on Revenue; Offers Q3 Guidance

Teradyne (NASDAQ: TER) reported Q2 EPS of $0.57, $0.03 better than the analyst estimate of $0.54. Revenue for the quarter came in at $652 million versus the consensus estimate of $649.52 million.

GUIDANCE:

Teradyne sees Q3 2025 EPS of $0.69-$0.87, versus the consensus of $0.89. Teradyne sees Q3 2025 revenue of $710-770 million, versus the consensus of $760 million.

For earnings history and earnings-related data on Teradyne (TER) click here.

You May Also Be Interested In

• Cinema United: issues joint letter to state AGs and Paramount
• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance